Follow
Jose S. Aguilar-Gallardo
Jose S. Aguilar-Gallardo
Verified email at mountsinai.org
Title
Cited by
Cited by
Year
Cardio-renal benefits of sodium–glucose co-transporter 2 inhibitors in heart failure with reduced ejection fraction: mechanisms and clinical evidence
JS Aguilar-Gallardo, A Correa, JP Contreras
European Heart Journal-Cardiovascular Pharmacotherapy 8 (3), 311-321, 2022
202022
Severe Obesity and Heart Failure
JS Aguilar-Gallardo, FJ Romeo, K Bhatia, A Correa, JI Mechanick, ...
The American Journal of Cardiology 177, 53-60, 2022
132022
Anticoagulation in COVID-19: a review of current literature and guidelines
B Narasimhan, M Lorente-Ros, JS Aguilar-Gallardo, CP Lizardo, ...
Hospital Practice 49 (5), 307-324, 2021
102021
Meta-Analysis Comparing Venoarterial Extracorporeal Membrane Oxygenation With or Without Impella in Patients With Cardiogenic Shock
K Bhatia, V Jain, MJ Hendrickson, D Aggarwal, JS Aguilar-Gallardo, ...
The American Journal of Cardiology 181, 94-101, 2022
92022
Cardio-Renal Benefits of SGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction: Mechanisms and Clinical Evidence
JS Aguilar-Gallardo, A Correa, JP Contreras
European Heart journal. Cardiovascular Pharmacotherapy, 2021
72021
The Effect of Colchicine on Mortality, Mechanical Ventilation, and Length of Stay in Patients With COVID-19 Infection: An Updated Systematic Review and Meta-analysis of …
FJ Romeo, L Barbagelata, JG Chiabrando, JI Damonte, E Moras, ...
American Journal of Therapeutics 29 (3), e344-e350, 2022
52022
An overview of mineralocorticoid receptor antagonists as a treatment option for patients with heart failure: the current state-of-the-art and future outlook
M Lorente-Ros, JS Aguilar-Gallardo, A Shah, B Narasimhan, WS Aronow
Expert Opinion on Pharmacotherapy 23 (15), 1737-1751, 2022
42022
Heart Failure with Reduced Ejection Fraction And COVID-19, When The Sick Get Sicker: Unmasking Racial and Ethnic Inequities During A Pandemic
J Contreras, EO Tinuoye, A Folch, J Aguilar, K Free, O Ilonze, S Mazimba, ...
Cardiology Clinics, 2023
32023
Successful treatment of cardiac sarcoidosis based on clinical suspicion and advanced cardiac imaging: A case report
JS Aguilar-Gallardo, J Arreaza, A Omar, G Lasam, JP Contreras
Medicine 101 (34), e30306, 2022
12022
ROLE OF CARDIAC BIOMARKERS IN PATIENTS WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY TREATED WITH CARDIAC MYOSIN INHIBITORS (CMI): A SYSTEMATIC REVIEW AND META-ANALYSIS
MI Khan, RS Zahir, MAV Martinez, PAL Osorio, JS Aguilar-Gallardo, ...
Journal of the American College of Cardiology 83 (13_Supplement), 530-530, 2024
2024
Minerva Cardiology and Angiology 2024 February; 72 (1): 95-7
FJ ROMEO, MG DEL BUONO, JS AGUILAR-GALLARDO, ...
Minerva 72, 2024
2024
Cardiac remodeling with SGLT2 inhibitors in heart failure with reduced ejection fraction
FJ Romeo, MG Del Buono, JS Aguilar-Gallardo, M Lorente-Ros, ...
Minerva cardiology and angiology 72 (1), 95-97, 2024
2024
In-hospital outcomes of transcatheter aortic valve replacement in patients with chronic and end-stage renal disease: a nationwide database study
M Lorente-Ros, S Das, A Malik, FJ Romeo, JS Aguilar-Gallardo, ...
BMC Cardiovascular Disorders 24 (1), 21, 2024
2024
Lactate Clearance And Mortality After Heart Transplantation: A Systematic Review And Meta-Analysis
MI Khan, JA Morales, M Lorente-Ros, JS Aguilar-Gallardo, FJ Romeo
Journal of Cardiac Failure 30 (1), 151, 2024
2024
TCT-547 In-Hospital Outcomes of TAVR in Patients With Chronic Kidney Disease: A Nationwide Database Study
M Lorente-Ros, S Das, L Wu, F Romeo, J Aguilar-Gallardo, A Patel
Journal of the American College of Cardiology 80 (12_Supplement), B224-B225, 2022
2022
CHARACTERISTICS AND HOSPITAL OUTCOMES OF PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES HOSPITALIZED WITH DIABETIC KETOACIDOSIS IN THE UNITED STATES.
T Bertasi, JS Aguilar-Gallardo, N Bilani, ME Garcia, DM Fermin, R Bertasi
JOURNAL OF GENERAL INTERNAL MEDICINE 37 (SUPPL 2), 177-177, 2022
2022
TYPE OF INSURANCE IS ASSOCIATED WITH INCREASED RATE OF DEPARTURE AGAINST MEDICAL ADVICE IN PATIENTS HOSPITALIZED FOR HEART FAILURE
JS Aguilar-Gallardo, R Bertasi, T Bertasi, N Bilani, DM Fermin, ME Garcia
JOURNAL OF GENERAL INTERNAL MEDICINE 37 (SUPPL 2), 196-197, 2022
2022
Klebsiella Pneumoniae Bacteremia Complicated by Aortic Valve Endocarditis with Pseudoaneurysm at the Aorto-Mitral Continuity
LN Danso, M Patel, J Eblacas, T Bertasi, JS Aguilar-Gallardo, G Osorio, ...
A46. INFECTIONS AND INFECTIOUS COMPLICATIONS IN THE ICU, A1620-A1620, 2022
2022
Clinically Ambiguous Hemorrhagic Cardiac Tamponade Associated with Apixaban
JS Aguilar-Gallardo, S Das, P Reddy, K Mahmood, A Fox
Cureus 14 (4), 2022
2022
Covid-19 Associated Lymphocytic Myocarditis With Genetic Predisposition
J Aguilar-Gallardo, J Arreaza, A Omar, J Contreras
Journal of Cardiac Failure 28 (5), S95-S96, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–20